Tuesday, Onyx Pharmaceuticals Inc. (ONXX) reported third-quarter net income of $8.2 million or $0.14 per share, compared to net income of $12.2 million or $0.21 per share in the same quarter last year.
On a non-GAAP basis, net income was $22.2 million or $0.35 per share, up from $16.6 million or $0.29 per share in the prior year quarter.
On average, 11 analysts polled by Thomson Reuters expected the company to earn $0.22 per share for the quarter. Analysts' estimates typically exclude special items.
Total operating revenue for the quarter was $69.1 million, up from $50.8 million in the comparable quarter last year. Analysts expected the company to report revenue of $65.22 million for the quarter.
For comments and feedback: editorial@rttnews.com